Metraipolis › archive › dc_185c6a9e2dca

Efficacy and safety of combination versus single-agent immunotherapy for BCG-unresponsive non-muscle-invasive bladder cancer — Europe PMC PMID:42582256

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42582256
DOI
10.3389/fimmu.2026.1896444
License (as archived)
solo-consultazione
Archived
2026-10-17T11:22:11.723Z
SHA-256 of the archived text
bf073438aea438f296de378acfae62c8f927314fc5323851c56f13633255d6ec
Stable URL of this page
https://metraipolis.com/documento/dc_185c6a9e2dca

How to cite

Efficacy and safety of combination versus single-agent immunotherapy for BCG-unresponsive non-muscle-invasive bladder cancer — Europe PMC PMID:42582256 — Europe PMC (en), https://europepmc.org/article/MED/42582256 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_185c6a9e2dca (Metraipolis archive dc_185c6a9e2dca, sha256 bf073438aea438f296de378acfae62c8f927314fc5323851c56f13633255d6ec)
BibTeX
@misc{dc185c6a9e2dca,
  title = {Efficacy and safety of combination versus single-agent immunotherapy for BCG-unresponsive non-muscle-invasive bladder cancer — Europe PMC PMID:42582256},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42582256},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_185c6a9e2dca; sha256 bf073438aea438f296de378acfae62c8f927314fc5323851c56f13633255d6ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42582256. Agents can read the archived copy with the MCP tool read_document.